The Management of ED TIA Patients:

Slides:



Advertisements
Similar presentations
Stroke Workshop Case Scenario.
Advertisements

Some Difficult Stroke Cases: What Would You Do?
Michael A. Ross, MD 1 Evaluating ED Patients with Transient Ischemic Attack: Inpatient vs. Outpatient Strategies.
Michael Ross, MD, FACEP The Management of ED TIA Patients: Michael A. Ross MD FACEP Associate Professor Emergency Medicine Department of Emergency Medicine.
Management of Stroke and Transient Ischaemic Attack Sam Thomson.
Latha G. Stead, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
STROKESTROKESTROKESTROKE. Why Change? Improve Mortality Improve Mortality Devastating and Life Altering Devastating and Life Altering Cost expense of.
1 Sixty-Four-Slice Computed Tomography of the Coronary Arteries: Cost-Effectiveness Analysis of Patients Presenting to the ED with Low Risk Chest Pain.
Stroke Mark Sudlow Consultant and Senior Lecturer
Michael A. Ross MD FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
ED TIA Patient Case Presentation Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral.
Canadian Cardiovascular Society Antiplatelet Guidelines
STROKE: 911 Emergency Learning Objectives for Stroke: 911 Emergency When you finish this course you will be able to answer the following questions: Where.
Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Atrial Fibrillation in Patients with Cryptogenic Stroke Gladstone DJ et al. N Engl J Med 2014; 370: Presented by Kris Huston | July 21, 2014.
Edward P. Sloan, MD, MPH FACEP ED Transient Ischemic Attack Patient Management: What Role for Outpatient Evaluation and Disposition?
J. Stephen Huff, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Stroke Issues & prevention. Agenda  Impact of Stroke –Definitions –Epidemiology –Risk factors  Management of Stroke –Acute management –Primary & Secondary.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
STROKE Dr Ubaid N P Community Medicine Pariyaram Medical College.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
Management of E.D. Patients who Present with a Transient Ischemic Attack or.
University of Michigan
Brian J. O’Neil MD, FACEP The Management of TIA Patients: The Science and the Practice.
Are Your Employees Receiving The Most Effective Physical Therapy? Stephen Hunter PT, OCS Administrator, Intermountain Rehabilitation Agency.
An Emergency Department Diagnostic Protocol For Patients With Transient Ischemic Attack: A Randomized Controlled Trial Michael A. Ross MD Scott Compton.
Preventing Strokes One at a Time Evaluating the Event 2009.
FERNE/EMRA The Management of ED TIA Patients: What is the optimal outpatient work-up, treatment and disposition?
Michael Ross, MD, FACEP The Management of ED TIA Patients: Can We Send Them Home, and What Work-up Must Be Done First?
“Six Publications That Influence Neurological Emergency Patient Resuscitation in 2010”
Edward P. Sloan, MD, MPH, FACEP EMRA /FERNE Case Conference: The ED Management of TIA, AIS and ICH Patients.
Jonathan A. Edlow, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral.
Transient Ischemic Attack (TIA): The Calm Before the Storm
Andrew Asimos, MD, FACEP ED Transient Ischemic Attack Patient Management: Can At-risk Ischemic Stroke Patients Be Identified?
High Risk TIA: Identification and Management Carolyn Walker RN. BN January 2011.
A Case of a Thunderclap Headache Andy Jagoda, MD, FACEP.
Stroke Quality Measures Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: May, 2012 Most recently updated: October,
Stroke Awareness & Prevention Suheb Hasan, MD Health Seminar MCWS November 17, 2012.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Consultant Neurologist,
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Secondary prevention after a TIA or ischemic stroke.
NYU Medical Grand Rounds Clinical Vignette Jacqueline Lonier, PGY2 November 3rd, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Simultaneous Coronary Artery Bypass and Carotid Endarterectomy Ye zhidong, Liu Peng Department of Cardiovascular Surgery China-Japan Friendship Hospital.
‘STROKE’ September 2010 Dr. Amer Jafar.
Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
NYU Medical Grand Rounds Clinical Vignette Karyn Singer, PGY3 September 22, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Acute Stroke: Principles of Modern Management A program of the American Academy of Neurology The AAN Acute Stroke Management courses are supported in part.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Stroke Damrongsak Bulyalert, M.D., Ph.D.
Jim Hoehns, Pharm.D.. Lancet 2013;382: Albers G et al. Chest. 2001; 119 (suppl): 300S. Ischemic stroke 85% Hemorrhagic stroke 15% Other 5% Cryptogenic.
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
Clinical Overview Director, Stanford Stroke Center Stanford University Palo Alto, California Gregory W. Albers, MD.
Rethinking TIA and Minor Stroke
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Ask for a smile Ask for a stretch The sky is blue in Boston Ask for a sentence BRAIN ATTACK - STROKE By: Saleem Ahmed Sangi ( )
Dr. Meg-angela Christi M. Amores
Rikki Weems, PGY III August 20, 2015
Cardioembolic Stroke: Diagnosis and Management
Emergency Medicine Junior Teaching Programme Aberdeen Royal Infirmary Adult Syncope Evaluation in the Emergency Department Jamie Cooper Teaching 4 th March.
Atrial Fibrillation Jay H. Lee, MD Denver Health Medical Center Wednesday 2 July 2008.
Risk Stratification of Chest Pain: Best Practices
Danielle Short, BSN, RN, SCRN
Cerebrovascular Disorders
Quality of Referrals Guideline Congruence of referrals to TIAMS clinic
Setareh Omran, MD Vascular Neurology Fellow
TIA/Stroke (1) C.L.I.P.S. Why do we care?
Presentation transcript:

The Management of ED TIA Patients: WBH Emergency Medicine Residency Grand Rounds May 31, 2007 Michael A. Ross MD FACEP Associate Professor Emergency Medicine Department of Emergency Medicine William Beaumont Hospital Wayne State University School of Medicine

Case presentation A 58 year old female presents to the emergency department after developing dysarthria, diploplia, numbness, and pronounced weakness of the right face and hand that lasted roughly 12 minutes. The patient feels completely normal and only came in at her families insistence. Review of systems - mild headache with event. No palpitations, chest pain, or SOB. Past medical history - Positive for hypertension and hyperlipidemia. No prior stroke or TIA. Family history positive for premature coronary disease. Meds - Beta-blocker for HTN. Not on aspirin. Social - She does not smoke.

Case presentation Phyisical Exam: On examination the patient was normotensive, and comfortable. HEENT exam showed no facial or oral asymmetry or numbness. No scalp tenderness. CHEST exam showed no murmurs and a regular rhythm, ABDOMINAL and EXTREMITY exam was normal, NEUROLOGICAL exam showed normal mentation, CN II-XII normal as tested, motor / sensory exam normal, symmetrical normal reflexes, and normal cerebellar exam.

Case presentation ED course: ECG showed a normal sinus rhythm with mild LVH. Non-contrast head CT scan was normal. Blood-work (CBC with differential, electrolytes, BUN/Cr, and glucose) was normal. ESR was normal. Monitor showed no dysrhythmias Normal subsequent neurological symptoms. The patient feels fine and is wondering if she can go home. What do you think?

Background 300,000 TIAs occur annually - Johnstons’ data Within 90 days: 10.5% will suffer a stroke 21% will be fatal 64% will be disabling Half of these will occur within 1 - 2 days of ED visit 2.6% will die 2.6% will suffer adverse cardiovascular events 12.7% will have additional TIAs

Stroke Risk After TIA Year N Stroke Risk Johnston, et al (Kaiser ED) 2000 1707 10.5% /90d Eliasew, et al (NASCET) 2004 603 20.1% /90d Lovett, et al (Oxfordshire) 2004 209 12% /30d Gladstone, et al (Toronto) 2004 371 5% /30d Daffertshofer, et al (Grmy) 2004 1150 13% /180d Hill, et al (Alberta) 2004 2285 9.5% /90d Lisabeth, et al (Texas) 2004 612 4.0% /90d Kleindorfer, et al (Cinc) 2005 927 14.6% /90d Whitehead, et al (Scotland)2005 205 7% /30d Correia, et al (Portugal) 2006 141 13% /7d Tsivgoulis, et al (Greece) 2006 226 9.7% /30d AVERAGE ~12% stroke risk in 90 days after TIA 5% in first 2 days

Stroke Risk After Stroke IST 3.3 %/ 3m CAST 1.6%/ 3m TOAST 5.7%/ 3m NASCET 2.3%/3m AVERAGE ~4% stroke risk in 90 days after stroke

Pathophysiology Short-term risk of stroke: Possible explanation After TIA (11%) > after stroke (4%) Possible explanation Tissue still at risk: unstable situation More thrombo-embolic events Johnston, NEJM 2002; 347:1687

Candidate Blood Markers??? Unstable plaque with intense staining for PAPP-A within spindle shaped smooth muscle cells and in extracellular matrix of eroded plaque Stable plaque with absence of PAPP-A staining Unstable plaque ; Lp-PLA2 Candidate Blood Markers??? Unstable Plaque: Lp-PLA2, PAPP-A, MMP-9, CRP, S-TF Coagulation Activation: D-dimer, F 1.2, TAT Cardioembolism: BNP (CHF), D-dimer

TIA: Differential Diagnosis “Mimics” Cervical disc disease Carpal tunnel syndrome Metabolic derangement (ex, hypoglycemia) Inner ear disease/BPV Transient global amnesia Cranial arteritis Epilepsy Complicated migraine Subdural hematoma Mass lesions, AVMs Arterial dissection Oxfordshire Community Stroke Project found that 62% of patients referred by GP with a diagnosis of TIA were found to have some other explanation for symptoms (Dennis M, Stroke 1989)

Is a “TIA” a TIA? Little agreement, even among neurologists (kappa 0.25-0.65) Generally, neurologists are not the ones making the diagnosis May even be less reproducibility Risk factors for stroke may identify true TIAs Johnston et al, Neurology 2003; 60:280

Utility of the H/P? TIA risk stratification Johnston criteria Rothwell criteria - “ABCD” Combination of the above = “ABCD2”

Risk factors were additive TIA risk stratification - California Model Johnston et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901-6. Independent risk factors for stroke: Age > 60yr (OR = 1.8) Diabetes (OR = 2.0) TIA > 10 min. (OR = 2.3) Weakness with TIA (OR = 1.9) Speech impairment (OR = 1.5) Risk factors were additive

Our patient’s Johnston score? Independent risk factors for stroke: Age > 60yr 0 Diabetes 0 TIA > 10 min. 1 Weakness with TIA 1 Speech impairment 1 stroke risk score of 3: ~5% at one week ~8% at 3 months

TIA risk stratification - British model. Rothwell,et al TIA risk stratification - British model? Rothwell,et al. Lancet 2005; 366: 29–36 A = Age >60 years = 1pt B = BP: SBP >140 or DBP >90 = 1pt C = Clinical: Unilateral weakness = 2pt Speech disturbance = 1pt D = Duration >60 min = 2pt 10 – 59 min = 1pt <10 min = 0pt

Our patients ABCD score? A = Age >60 years = 0 B = BP: SBP >140 or DBP >90 = 0 C = Clinical: Unilateral weakness = 2pt Speech disturbance = 1pt D = Duration >60 min = 0 10 – 59 min = 1pt <10 min = 0 TOTAL SCORE = 4 (5% risk of stroke at one week)

ABCD2 Score

ABCD2 Score Score points for each of the following: Final Score 0-7 Age >60 (1) Blood pressure >140/90 on initial evaluation (1) Clinical: Focal weakness (2) Speech impairment without weakness (1) Duration >60 min (2) 10-59 min (1) Diabetes (1) Final Score 0-7

ABCD2 Score Validation: Meta-analysis

ABCD2 Score and Stroke Risks

Prognosis Conclusions The ABCD2 Score stratifies short-term risk of stroke after TIA 2-day risks Low Risk (34%): Score 0-3  1% Moderate Risk (45%): Score 4-5  4% Very High Risk (21%): Score 6-7  8% “This rule is ready for clinical use” C. Johnston

What is our patients’ ABCD2 score? Age >60 = 0 Blood pressure >140/90 (initial) (1) = 0 Clinical: Focal weakness (2) = 2 Speech impairment without weakness (1) = 0 Duration >60 min (2) = 0 10-59 min (1) = 1 Diabetes (1) = 0 Total = 3 Stroke at 2 days = 1% Stroke at 7 days = 2% (?!)

Limitations of Prediction Rules Discriminatory value sub-optimal What about the patient with 90% carotid stenosis and a low score??? Generalizability seems poor (though exact reasons for this unclear) Are these rules really just selecting patients with “real” TIAs?

2. HCT, ECG HCT - tumor, SDH, NPH, etc Minor stroke and TIA associated with a 10% incidence of stroke on MRI.

Infarction in TIA Approximately 50% of those with TIA have DWI changes on MRI Kidwell et al Stroke 1999

TIA Stroke Reversible ischemia Infarction Minor stroke DWI+ TIA Reversible ischemic neurologic deficit (RIND) Stroke Cerebral infarction with transient signs

2. HCT, ECG ECG – ATRIAL FIBRILLATION!!! Stroke risk – cardio-embolic risk 4.6% at 1 month 11.9% at 3 months 61% reduction in annual risk of stroke (both ischemic or hemorrhagic) with coumadin

3. Carotid Dopplers Stroke risk depends on where the disease is: 7day 90day CE = Cardio-Embolic: 2.5% 12% LAA = Large arteries 4.0% 19% Und = Undetermined 2.3% 9% SVS = Small Vessels 0% 3%

Outpatient carotid dopplers? Office management of TIA??? Goldstein et al. New transient ischemic attack and stroke: outpatient management by primary care physicians. Arch Intern Med. 2000;160:2941-6. Design: Retrospective study of 95 TIA and 81 stroke patients seen in office Diagnostic testing within 30 days: 23% had head CT done 40% had carotid dopplers done 18% had ECG done 19% had echo done 31% had no other evaluation

5. Medical management Antiplatelet Therapy Useful in non-cardioembolic causes Aspirin 50-325 mg/day Clopidogrel or ticlopidine Aspirin plus dipyridamole Latter two if ASA intolerant or if TIA while on ASA Routine anticoagulation not recommended

5. Medical management Risk Factor Management HTN: BP below 140/90 DM: fasting glucose < 126 mg/dl Hyperlipidemia: LDL < 100 mg/dl Stop smoking! Exercise 30-60 min, 3x/week Avoid excessive alcohol use Weight loss: < 120% of ideal weight

Hospital Admission for TIA Medical management to minimize risk of recurrent ischemia Expedite evaluation and treatment of specific mechanisms – CEA for carotid stenosis, anticoagulation for atrial fibrillation Observation for further events, with potential expedited thrombolysis Avoid the lawyers

Management of TIA: Areas of Certainty: Need for ED visit, ECG, labs, Head CT Areas of less certainty The timing of the carotid dopplers Areas of Uncertainty - Johnston SC. N Engl J Med. 2002;347:1687-92. “The benefit of hospitalization is unknown. . . Observation units within the ED. . . may provide a more cost-effective option.”

An Emergency Department Diagnostic Protocol For Patients With Transient Ischemic Attack: A Randomized Controlled Trial To determine if emergency department TIA patients managed using an accelerated diagnostic protocol (ADP) in an observation unit (EDOU) will experience: shorter length of stays lower costs comparable clinical outcomes . . . relative to traditional inpatient admission.

Patient population: ED evaluation: Presented to the ED with symptoms of TIA ED evaluation: History and physical ECG, monitor, HCT Appropriate labs Diagnosis of TIA established Decision to admit or observe SCREENING AND RANDOMIZATION

Methods: ADP Interventions Four components: Serial neuro exams Unit staff, physician, and a neurology consult Cardiac monitoring Carotid dopplers 2-D echo BOTH study groups had orders for the same four components

Methods: ADP Disposition criteria Home No recurrent deficits, negative workup Appropriate antiplatelet therapy and follow-up Inpatient admission from EDOU Recurrent symptoms or neuro deficit Surgical carotid stenosis (ie >50%) Embolic source requiring treatment Unable to safely discharge patient

Results: Performance of clinical testing

Results: Length of Stay Median Inpatient = 61.2 hr ADP = 25.6 hr Difference = 29.8 hr (Hodges-Lehmann) (p<0.001) ADP sub-groups: ADP - home = 24.2 hr ADP - admit = 100.5 hr

Results: 90-Day Clinical Outcomes

Results: 90 - day Costs Median Inpatient = $1548 ADP = $890 Difference = $540 (Hodges-Lehmann) (p<0.001) ADP sub-groups: ADP - home = $844 ADP - admit = $2,737

Study conclusion: Compared to inpatient admission, the ED TIA diagnostic protocol was: More efficient Less costly With comparable clinical outcomes

Implications National feasibility of ADP: 18% of EDs have an EDOU 220 JCAHO stroke centers National health care costs Potential savings if 18% used ADP: $29.1 million dollars Medicare observation APC Impact of shorter LOS Patients – satisfaction, missed Dx . . . Hospitals – bed availability

CLINICAL CASE - OUTCOME The patient was started on aspirin and admitted to the ED observation unit. While in the unit she had a 2-D echo with bubble contrast, that was normal. She had no arrhythmia detected on cardiac monitoring and no subsequent neurological deficits. However, carotid dopplers were abnormal. She showed 30-50% stenosis of the right internal carotid artery, and a severe flow limiting >70% stenosis of the left carotid artery at the origin of the internal carotid artery. She was admitted to the hospital for endarterectomy. Five days following ED arrival, and following inpatient pre-operative clearance, she underwent successful endarterectomy. On one month follow-up she was asymptomatic and her carotids were doing well.

Who do you send home from the ED??? C. Johnston: “TIA risk score does not identify a “zero” risk group” But it is a good start. . . Possibly: Negative ED work-up (ECG, exam, CT), low TIA score, negative carotid dopplers within 6 months, safe home support for return in next 48 hours if needed? Appropriate medications.

Who do you send home from the ED??? Ron Krome: “It doesn’t matter what you do, as long as you are right” If you are not sure, better play it safe. . . Admit or observe

Conclusions TIAs are ominous Justifies acute interventions, including hospitalization Opportunity to prevent injury but trials are needed Recovery rather than complete resolution is likely the important distinguishing characteristic and may identify an unstable pathophysiology “TIAs” are heterogeneous Management should be individualized Prognostic scores may help Secondary prevention is critical ferne_aaem_2008_lecture_Ross_Bunney_072208_final 4/19/2017 2:05 AM